These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15715182)

  • 1. Past, present and future--beta2-adrenoceptor agonists in asthma management.
    Sears MR; Lötvall J
    Respir Med; 2005 Feb; 99(2):152-70. PubMed ID: 15715182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
    Campbell LM
    Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting inhaled beta2-agonists in asthma therapy.
    Moore RH; Khan A; Dickey BF
    Chest; 1998 Apr; 113(4):1095-108. PubMed ID: 9554653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of beta2-agonists.
    Sears MR
    Respir Med; 2001 Aug; 95 Suppl B():S2-6. PubMed ID: 11534892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
    Rabe KF
    Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of long-acting beta2-adrenoceptor agonism.
    Lipworth BJ
    Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi.
    Molimard M; Naline E; Zhang Y; Le Gros V; Begaud B; Advenier C
    Eur Respir J; 1998 Mar; 11(3):583-8. PubMed ID: 9596106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological similarities and differences between beta2-agonists.
    Lötvall J
    Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting beta(2)-agonists in the management of asthma exacerbations.
    Hospenthal MA; Peters JI
    Curr Opin Pulm Med; 2005 Jan; 11(1):69-73. PubMed ID: 15591891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
    Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.
    Hancox RJ; Taylor DR
    BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β2-agonist therapy in lung disease.
    Cazzola M; Page CP; Rogliani P; Matera MG
    Am J Respir Crit Care Med; 2013 Apr; 187(7):690-6. PubMed ID: 23348973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.